60 Degrees Pharmaceuticals (SXTP) Inventory Average (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Inventory Average of $909602.0 for Q1 2026, up 49.61% year-over-year from $608001.0 in Q1 2025, and up 26.72% quarter-over-quarter from $717802.5 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Inventory Average (2023 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Inventory Average for 4 consecutive years, with $909602.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 49.61% year-over-year to $909602.0; the TTM figure through Mar 2026 stood at $909602.0 (up 49.61% YoY), while the FY2025 annual figure was $675682.5, up 48.68% from the prior year.
- Inventory Average climbed to $909602.0 in Q1 2026 per SXTP's latest filing, from $717802.5 in the prior quarter.
- Across five years, Inventory Average topped out at $909602.0 in Q1 2026 and bottomed at $430698.5 in Q2 2024.
- Historically, Inventory Average has averaged $604987.1 across 4 years, with a median of $608001.0 in 2025.
- Annual changes were most pronounced in 2024 — Inventory Average slumped 34.45% — and 2025, when it surged 82.57%.
- 60 Degrees Pharmaceuticals' Inventory Average stood at $532244.0 in 2023, then slipped by 15.94% to $447400.0 in 2024, then jumped by 60.44% to $717802.5 in 2025, then rose by 26.72% to $909602.0 in 2026.
- Business Quant data shows SXTP's Inventory Average at $909602.0 in Q1 2026, $717802.5 in Q4 2025, and $663212.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 894,274.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 909,602.00 |
| Dec 31, 2025 | 717,802.50 |
| Sep 30, 2025 | 663,212.50 |
| Jun 30, 2025 | 786,329.50 |
| Mar 31, 2025 | 608,001.00 |
| Dec 31, 2024 | 447,400.00 |
| Sep 30, 2024 | 439,028.00 |
| Jun 30, 2024 | 430,698.50 |
| Mar 31, 2024 | 450,773.00 |
| Dec 31, 2023 | 532,244.00 |
| Sep 30, 2023 | 669,767.50 |